Company intelligence / Profile preview

Orbit Co-Invest III

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Orbit Co-Invest III is a Delaware limited liability company used as a co-investment vehicle affiliated with Avista Healthcare Partners. Public SEC documents show it participated as a shareholder in Osmotica Pharmaceuticals and was grouped with Avista-sponsored investment entities rather than described as an operating biotechnology or pharmaceutical company. The entity appears to function as a financial holding vehicle for private equity investments, not as a developer of therapeutics, diagnostics, or healthcare services. As a result, it does not have a clinical pipeline, therapeutic platform, or product portfolio of its own.

Industry: Investors

Partnerships

Osmotica Pharmaceuticals (portfolio/shareholding relationship)

Beyond the preview

Go deeper on Orbit Co-Invest III.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orbit Co-Invest III.

Explore the full profile